Phase IB study of the EpCAM antibody adecatumumab combined with docetaxel in patients with EpCAM-positive relapsed or refractory advanced-stage breast cancer.
Ann Oncol
; 23(9): 2306-2313, 2012 Sep.
Article
in En
| MEDLINE
| ID: mdl-22357251
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Breast Neoplasms
/
Antineoplastic Combined Chemotherapy Protocols
/
Cell Adhesion Molecules
/
Drug Resistance, Neoplasm
/
Liver Neoplasms
/
Antigens, Neoplasm
/
Neoplasm Recurrence, Local
Type of study:
Clinical_trials
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Middle aged
Language:
En
Journal:
Ann Oncol
Journal subject:
NEOPLASIAS
Year:
2012
Document type:
Article
Affiliation country:
Germany
Country of publication:
United kingdom